Oral squamous cell carcinoma patients can be differentiated from healthy individuals with label-free serum proteomics

British Journal of Cancer

Volumn 117, Issue 3, 2017, Pages 376-384

  Saraswat, Mayank ^a,b   Mäkitie, Antti ^a   Agarwal, Rahul ^c   Joenvaärä, Sakari ^a,b   Renkonen, Suvi ^a,d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c GENXPRO GMBH   (Germany)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

ARTICLE; CANCER PATIENT; CANCER SCREENING; CHEMICAL LABELING; CLINICAL ARTICLE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; FINLAND; HUMAN; LABEL FREE SERUM PROTEOMICS; MOUTH SQUAMOUS CELL CARCINOMA; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS; STRUCTURE ANALYSIS; UNIVERSITY HOSPITAL; AREA UNDER THE CURVE; BLOOD; CASE CONTROL STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PATHOLOGY; PILOT STUDY; RECEIVER OPERATING CHARACTERISTIC; SECONDARY; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR;

AREA UNDER CURVE; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; DISCRIMINANT ANALYSIS; HUMANS; MASS SPECTROMETRY; PILOT PROJECTS; PRINCIPAL COMPONENT ANALYSIS; PROTEOMICS; ROC CURVE; TONGUE NEOPLASMS;

EID: 85029282002     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2017.172     Document Type: Article

References (44)

1. Bagan JV, Scully C (2008) Recent advances in Oral Oncology 2007: Epidemiology, aetiopathogenesis, diagnosis and prognostication. Oral Oncol 44(2): 103-108.
2. Braakhuis BJ, Leemans CR, Visser O (2014) Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011. Oral Oncol 50(7): 670-675.
3. Camp ER, Liu W, Fan F, Yang A, Somcio R, Ellis LM (2005) RON, a tyrosine kinase receptor involved in tumour progression and metastasis. Ann Surg Oncol 12(4): 273-281.
4. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, Rosenberg PS, Bray F, Gillison ML (2013) Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 31(36): 4550-4559.
5. Covell DG, Wallqvist A, Rabow AA, Thanki N (2003) Molecular classification of cancer: Unsupervised self-organizing map analysis of gene expression microarray data. Mol Cancer Ther 2(3): 317-332.
6. Dahiya K, Dhankhar R (2016) Updated overview of current biomarkers in head and neck carcinoma. World J Methodol 6(1): 77-86.
7. Decker J, Goldstein JC (1982) Risk factors in head and neck cancer. N Engl J Med 306(19): 1151-1155.
8. Di Luca A, Henry M, Meleady P, O'Connor R (2015) Label-free LC-MS analysis of HER2\+ breast cancer cell line response to HER2 inhibitor treatment. Daru 23(1): 40.
9. Droin N, Hendra JB, Ducoroy P, Solary E (2009) Human defensins as cancer biomarkers and antitumour molecules. J Proteomics 72(6): 918-927.
10. Falanga A, Marchetti M, Vignoli A (2013a) Coagulation and cancer: Biological and clinical aspects. J Thromb Haemost 11(2): 223-233.
11. Falanga A, Russo L, Verzeroli C (2013b) Mechanisms of thrombosis in cancer. Thromb Res 131(Suppl 1): S59-S62.
12. Gaudino G, Avantaggiato V, Follenzi A, Acampora D, Simeone A, Comoglio PM (1995) The proto-oncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues. Oncogene 11(12): 2627-2637.
13. Gerotziafas GT, Elalamy I, Lecrubier C, Lebrazi J, Mirshahi M, Potevin F, Lecompte T, Samama MM (2001) The role of platelet factor 4 in platelet aggregation induced by the antibodies implicated in heparin-induced thrombocytopenia. Blood Coagul Fibrinolysis 12(7): 511-520.
14. Hsu YP, Hsieh CH, Chien HT, Lai CH, Tsao CK, Liao CT, Kang CJ, Wang HM, Chang JT, Huang SF (2015) Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma. World J Surg Oncol 13: 253.
15. Iwama A, Wang MH, Yamaguchi N, Ohno N, Okano K, Sudo T, Takeya M, Gervais F, Morissette C, Leonard EJ, Suda T (1995) Terminal differentiation of murine resident peritoneal macrophages is characterized by expression of the STK protein tyrosine kinase, a receptor for macrophage-stimulating protein. Blood 86(9): 3394-3403.
16. Kamburov A, Cavill R, Ebbels TMD, Herwig R, Keun HC (2011) Integrated pathway-level analysis of transcriptomics and metabolomics data with IMPaLA. Bioinformatics 27(20): 2917-2918.
17. Karantza V (2011) Keratins in health and cancer: More than mere epithelial cell markers. Oncogene 30(2): 127-138.
18. Keller J, Nimnual AS, Shroyer KR, Joy C, Ischenko I, Chandler CS, Dong LM, Hayman MJ, Chan EL (2013) Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma. Br J Cancer 109(2): 482-492.
19. Kohonen T (1997) Self-organizing Maps. Vol. 117, Springer: Berlin, Germany.
20. Kohonen T (2012) Self-organizing Maps. Springer: Berlin, Germany.
21. Kuang LI, Song WJ, Qing HM, Yan S, Song FL (2015) CYFRA21-1 levels could be a biomarker for bladder cancer: A meta-analysis. Genet Mol Res 14(2): 3921-3931.
22. Kuusela P, Saraswat M, Joenvaärä S, Kaartinen J, Järvinen A, Renkonen R (2017) Changes in plasma protein levels as an early indication of a bloodstream infection. PLoS One 12(2): E0172987.
23. Lee HJ, Kim YT, Park PJ, Shin YS, Kang KN, Kim Y, Kim CW (2012) A novel detection method of non-small cell lung cancer using multiplexed bead-based serum biomarker profiling. J Thorac Cardiovasc Surg 143(2): 421-427.
24. Lin HS, Berry GJ, Fee Jr WE, Terris DJ, Sun Z (2004) Identification of tyrosine kinases overexpressed in head and neck cancer. Arch Otolaryngol Head Neck Surg 130(3): 311-316.
25. Liu T-C, Zhang T, Fukuhara H, Kuroda T, Todo T, Martuza RL, Rabkin SD, Kurtz A (2006) Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy. Mol Ther 14(6): 789-797.
26. Lundy FT, Orr DF, Gallagher JR, Maxwell P, Shaw C, Napier SS, Gerald Cowan C, Lamey PJ, Marley JJ (2004) Identification and overexpression of human neutrophil alpha-defensins (human neutrophil peptides 1, 2 and 3) in squamous cell carcinomas of the human tongue. Oral Oncol 40(2): 139-144.
27. Lustberg MB (2012) Management of neutropenia in cancer patients. Clin Adv Hematol Oncol 10(12): 825-826.
28. Machiels JP, Lambrecht M, Hanin FX, Duprez T, Gregoire V, Schmitz S, Hamoir M (2014) Advances in the management of squamous cell carcinoma of the head and neck. F1000Prime Rep 6: 44.
29. Madsen BE, Ramos EM, Boulard M, Duda K, Overgaard J, Nordsmark M, Wiuf C, Hansen LL (2008) Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer. PLoS One 3(6): E2492.
30. Mosesson Y, Mills GB, Yarden Y (2008) Derailed endocytosis: An emerging feature of cancer. Nat Rev Cancer 8(11): 835-850.
31. Pio R, Ajona D, Lambris JD (2013) Complement inhibition in cancer therapy. Semin Immunol 25(1): 54-64.
32. Razzouk S (2014) Translational genomics and head and neck cancer: Toward precision medicine. Clin Genet 86(5): 412-421.
33. Reddi KK, Holland JF (1976) Elevated serum ribonuclease in patients with pancreatic cancer. Proc Natl Acad Sci USA 73(7): 2308-2310.
34. Saraswat M, Joenvaärä S, Jain T, Tomar AK, Sinha A, Singh S, Yadav S, Renkonen R (2016) Human spermatozoa quantitative proteomic signature classifies normo-A nd asthenozoospermia. Mol Cell Proteomics 16(1): 57-72.
35. Serang O, Moruz L, Hoopmann MR, Käll L (2012) Recognizing uncertainty increases robustness and reproducibility of mass spectrometry-based protein inferences. J Proteome Res 11(12): 5586-5591.
36. Shen W, Sakamoto N, Yang L (2015) Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: A competing risk analysis. Ann Surg Oncol 22(1): 264-271.
37. Silva JC, Gorenstein MV, Li G-Z, Vissers JPC, Geromanos SJ (2006) Absolute quantification of proteins by LCMSE: A virtue of parallel ms acquisition. Mol Cell Proteomics 5(1): 144-156.
38. Smith EM (1979) Epidemiology of oral and pharyngeal cancers in the United States: Review of recent literature. J Natl Cancer Inst 63(5): 1189-1198.
39. SunW, Zhang X, Ding X, Li H, Geng M, Xie Z, Wu H, Huang M (2015) Lactate dehydrogenase B is associated with the response to neoadjuvant chemotherapy in oral squamous cell carcinoma. PLoS One 10(5): E0125976.
40. Van Dijk BA, Brands MT, Geurts SM, Merkx MA, Roodenburg JL (2016) Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands. Int J Cancer 139(3): 574-583.
41. Vizcaino JA, Csordas A, Del-Toro N, Dianes JA, Griss J, Lavidas I, Mayer G, Perez-Riverol Y, Reisinger F, Ternent T, Xu QW, Wang R, Hermjakob H (2016) 2016 update of the PRIDE database and its related tools. Nucleic Acids Res 44(D1): D447-D456.
42. Wynder EL, Mushinski MH, Spivak JC (1977) Tobacco and alcohol consumption in relation to the development of multiple primary cancers. Cancer 40(4 Suppl): 1872-1878.
43. Yoon TM, Kim SA, Park YL, Lee KH, Sung MW, Lee JK, Lim SC, Chung IJ, Joo YE (2013) Expression of the receptor tyrosine kinase recepteur d'origine nantais and its association with tumour progression in hypopharyngeal cancer. Head Neck 35(8): 1106-1113.
44. Zhao Z, Han F, Yang S, Wu J, Zhan W (2015) Oxamate-mediated inhibition of lactate dehydrogenase induces protective autophagy in gastric cancer cells: Involvement of the Akt-mTOR signaling pathway. Cancer Lett 358(1): 17-26.